With 140 employees and more than 300 clinical trials performed in over 35 countries, MCT is the leading CRO in MEA region (Middle-East & Africa) and Pakistan. Working with many international pharmaceutical & biotech companies from all the globe (US, Europe, Asia) we are the renowned expert of MEA and Pakistan, enabling us to guide you through each country specificities (regulatory process, patient flow, health care system) and select the best sites for your clinical trials. Our experience in clinical trials in the region is wide and unique: infectious disease (including COVID 19), tropical disease, hematology, rare disease, cardiology, oncology, diabetes … MCT is your partner of choice for MEA and Pakistan.
WHY CHOOSE US
We support our sponsors with our local expertise of MEA and Pakistan: optimized startup (site selection & regulatory submission) and site management (proximity, cultural understanding, privileged communication).
MCT is the only CRO covering the whole MEA region and Pakistan through its own staff and local offices. We have developed a unique knowledge of the filed, making MCT the EXPERT of these regions.
MCT team is very experienced at all levels: Clinical Project Leads, Regulatory Officers, CRAs. Our team is made of professionals combining international experience with local expertise. They are MCT best value, contributing every day, by their skills and knowledge, to the success of your clinical trials.
MCT spirit and value are focused on Rigor, professionalism, respect of Deadline and above all: Client satisfaction